Renalytix is a pioneering company in the emerging field of bioprognosis for kidney health. Its innovative solution allows for early-stage risk assessment, helping patients manage their condition before it progresses too far. Renalytix is a global leader in this space and is listed on both the London Stock Exchange and NASDAQ.
Renalytix AI plc's ticker is RENX
The company's shares trade on the LSE stock exchange
They are based in London, England
There are 1-10 employees working at Renalytix AI plc
It is https://renalytixai.com/
Renalytix AI plc is in the Healthcare sector